Predictors of mortality in paediatric myocarditis

Journal of Clinical and Diagnostic Research

Volumn 10, Issue 6, 2016, Pages SC12-SC16

  Abrar, Shahla ^a   Ansari, Mohammed Junaid ^a   Mittal, Mahima ^a   Kushwaha, K P ^a  

^a BRD MEDICAL COLLEGE   (India)

Author keywords

Brain natriuretic peptide; Cardiac markers; Ejection fraction; Troponin I

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE; TROPONIN I;

ARTICLE; CARDIOVASCULAR MORTALITY; CHILD; CHILDHOOD MORTALITY; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPOTENSION; LENGTH OF STAY; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MYOCARDITIS; OBSERVATIONAL STUDY; PRESCHOOL CHILD; THORAX RADIOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 84973299029     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2016/19856.7967     Document Type: Article

References (35)

1. Towbin JA, Lowe AM, Colan SD, Sleeper LA, Orav EJ, Clunie S, et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA. 2006; 296(15):1867-76.
2. Feldman AM, McNamara D. Myocarditis. NEngl JMed. 2000;343(19):1388-98.
3. Dancea AB. Myocarditis in infants and children: a review for the paediatrician. J Paediatr Child Health. 2001;343:1388-98.
4. Drucker NA, Colan SD, Lewis AB, Beiser AS, Wessel DL, Takahashi M, et al. Globulin treatment of acute myocarditis in the paediatric population. Circulation. 1994;89:252-57.
5. Woodruff JF. Viral myocarditis: a review. Am J Pathol. 1980;101:425-84.
6. Lieberman EB, Hutchins GM, Herskowitz A, Rose NR, Baughman KL. Clinicopathologic description of myocarditis. J Am Coll Cardiol. 1991;18:1617-26.
7. Liu PP, Schultheiss HP. Myocarditis. In:. Braunwald’s heart disease: a textbook of cardiovascular medicine. (Volume 2). Libby P, Braunwald E (Ed.), W. B. Saunders, Philadelphia, 2008;1784-1785.
8. Roeland J, Gibson DG. Recommendations for standardization of measurements from M-mode echocardiograms. Eur Heart J. 1980;1:375-78.
9. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocar- diographic measurements. Circulation. 1978;58:1072-83.
10. Kampmann C, Wiethoff CM, Wenzel A, Stolz G, Betancor M, Wippermann C-F, et al. Normal values of M mode echocardiographic measurements of more than 2000 healthy infants and children in central Europe. Heart. 2000;83(6):667-72.
11. Soongswang J, Durongpisitkul K, Nana A, Laohaprasittiporn D, Kangkagate C, Punlee K, et al. Cardiac troponin T: a marker in the diagnosis of acute myocarditis in children. Paediatr Cardiol. 2005;26:45-49.
12. Schwartz J, Sartini D, Huber S. Myocarditis susceptibility in female mice depends upon ovarian cycle phase at infection. Vrology. 2004;330(1):16-23.
13. Hsiao HJ, Hsia SH, Wu CT, Lin JJ, Chung HT, Hwang MS, et al. Clinical presentation of paediatric myocarditis in taiwan. Paediatr Neonatol. 2011;52(3):135-39.
14. Why HJ, Meany BT, Richardson PJ, Olsen EG, Bowles NE, Cunningham L, et al. Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation. 1994;89:2582-89.
15. Hochholzer W, Morrow DA, Giugliano RP. Novel biomarkers in cardiovascular disease: update 2010. Am Heart J. 2010;160:583-94.
16. Leeper NJ, Wener LS, Dhaliwal G, Saint S, Wachter RM. Clinical problem-solving. One surprise after another. N Engl J Med. 2005;352(14):1474-79.
17. Lauer B, Niederau C, Kuhl U, Schannwell M, Pauschinger M, Strauer BE, et al. Cardiac troponin T in patients with clinically suspected myocarditis. J Am Coll Cardiol. 1997;30(5):1354-59.
18. Cooper LT Myocarditis. N Engl J Med. 2009;360(15):1526-38.
19. Smith SC, Ladenson JH, Mason JW, Jaffe AS. Elevations of cardiac troponin associated with myocarditis. Experimental and clinical correlates. Circulation. 1997;95(1):163-68.
20. Stankewicz MA, Clements SD. Fulminant myocarditis presenting with wide complex tachycardia. South Med J. 2004;97(10):1007-09.
21. Oshima K, Kunimoto F, Hinohara H, Hayashi Y, Hirato J, Tajima Y, et al. Fulminant myocarditis treated with percutaneous cardiopulmonary support system (PCPS). Ann Thorac Cardiovasc Surg. 2008;4(2):75-80.
22. Braunwald E. Biomarkers in heart failure. N Engl J Med. 2008;358:2148-59.
23. Chen WC, Tran KD, Maisel AS. Biomarkers in heart failure. Heart. 2010;96:314-20.
24. Grabowski M, Karpinski GJ, Filipiak K, Rdzanek A, Pietrasik A, Wretwoski D, et al. Diagnostic value of BNP in suspected perimyocarditis- a preliminary report. Kardiol Pol. 2004;61:451-58.
25. Miller W, Hartman KA, Burritt MF, Burnett JC, Jaffe AS. Troponin, B-type natriuretic peptides and outcomes in severe heart failure: differences between ischemic and dilated cardiomyopathies. Clin Cardiol. 2007;30:245-50.
26. Ogawa T, Veinot JP, de Kuroski, Bold ML, Georgalis T, de Bold AJ. Angiotensin receptor antagonism reverts the selective cardiac BNP upregulation and secretion observed in myocarditis. Am J Physiol Heart Circ Physiol. 2008; 294:H2596-603.
27. Talvani A, Rocha MO, Barcelos LS, Gomes YM, Ribeiro AL, Teixeira MM. Elevated concentrations of CCL2 and tumor necrosis factor-alpha in chagasic cardiomyopathy. Clin Infect Dis. 2004;38:943-50.
28. Tanaka K, Ito M, Kodama M, Tomita M, Kimura S, Hoyano M, et al. Sulfated polysaccharide fucoidan ameliorates experimental autoimmune myocarditis in rats. Journal of Cardiovascular Pharmacology and Therapy. 2011;16:79-86.
29. Palazzuoli A, Antonelli G, Quantrini I, Nuti R. Natriuretic peptides in heart failure: where we are, where we are going. Internal Emergency Medicine. 2011;6:63-68.
30. Masson S, Latini R, Anand IS, Vago T, Angelici L, Barlera S, et al. Direct comparison of Btype natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Fialure (Val-HeFT) data. Clinical Chemistry. 2006;52:1528-38.
31. Omland T, Sabatine MS, Jablonski KA, Rice MM, Hsia J, Wergeland R, et al. Prognostic value of B-type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial. J Am Coll of Cardiol. 2007;50:205-14.
32. Anand IS, Fisher L D, Chiang Y T, Latini R, Masson s, Maggioni AP, et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the valsartan heart failure. trial (Val-HeFT). Circulation. 2003;107:1278-83.
33. Schultz JC, Hilliard AA, Cooper LT, Rihal CS. Diagnosis and treatment of viral myocarditis. Mayo Clin Proc. 2009;84:1001-09.
34. Magnani JW, Suk-Danik HJ, Dec GW, DiSalvo TG. Survival in biopsy-proven myocarditis: a long-term retrospective analysis of the histopathologic, clinical, and hemodynamic predictors. Am Heart J.2006;151(2):463-70.
35. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O’Connell J, et al. Report of the 1995 world health organization/international society and federation of cardiology task force on the definition and classification of cardiomyopathies. Circulation. 1996;93:841-42.